Global Factor IX Drug Pipeline Landscape Report 2024: Therapeutic Assessment by Stage, Route of Administration, and Molecule Type
29 févr. 2024 10h52 HE
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Factor IX - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
von Willebrand Disease (vWD) Therapeutics Market Analysis 2023-2032: Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs
23 janv. 2024 16h53 HE
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032" report...
Hemophilia Market Size, Share & Trends Analysis Report 2023-2030
21 août 2023 08h48 HE
|
Research and Markets
Dublin, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The "Hemophilia Market Size, Share & Trends Analysis Report By Type (Hemophilia A), By Treatment Type (On-demand), By Therapy (Gene Therapy &...
Worldwide Hemophilia Treatment Industry to 2030 - by Product, Hemophilia Type and Region
02 févr. 2023 12h43 HE
|
Research and Markets
Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Global Hemophilia Treatment Market Report to 2031: Players Include Bayer, Pfizer, F. Hoffmann-La Roche and CSL
11 nov. 2022 04h50 HE
|
Research and Markets
Dublin, Nov. 11, 2022 (GLOBE NEWSWIRE) -- The "Hemophilia Treatment Market By Type, By Drug Therapy: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ...
Global Bleeding Disorders Treatment Market Report 2022: Increased Focus of Pharmaceutical Companies on Recombinant Products Creates Opportunities
09 sept. 2022 07h33 HE
|
Research and Markets
Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Global Bleeding Disorders Treatment Market By Drug Type, By Disease Type, By Distribution Channel, By End User By Region, Competition, Forecast &...
United States Thrombotic Thrombocytopenic Purpura (TTP) Market Research Report 2021-2030 Featuring Sanofi, Octapharma, Baxalta/Takeda, & Omeros
18 nov. 2021 05h28 HE
|
Research and Markets
Dublin, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The "US Thrombotic Thrombocytopenic Purpura (TTP) Market Insight, Epidemiology and Market Forecast -2030" report has been added to ResearchAndMarkets.com's...
Global Human Coagulation Factor IX Market Insights (2021 to 2025) - Key Analysis and Forecasts
31 août 2021 05h43 HE
|
Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "Human Coagulation Factor IX Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product...
Plasma Fractionation Market Size is Expected to Reach $23.00 Billion by 2027: Says AMR
21 avr. 2021 10h10 HE
|
Allied Market Research
Portland, OR, April 21, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Plasma Fractionation Market was estimated at $18.22 billion in 2019 and is...
Global $24.07 Billion Bleeding Disorders Drugs Markets, Competition Forecast & Opportunities, 2026 - Recombinant Coagulation Factor Concentrates Dominated the Market with 52.91% Share in 2020
19 avr. 2021 06h53 HE
|
Research and Markets
Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "Global Bleeding Disorders Drugs Market, By Drug Type (Plasma-derived Coagulation Factor Concentrates, Desmopressin, Others), By Disease Type, By...